132 related articles for article (PubMed ID: 38615375)
1. Drug-related pneumonitis caused by amikacin liposome inhalation suspension: One pathologically proven case and single-center experience.
Kaneko T; Otoshi R; Sekine A; Baba T; Yamada C; Haga S; Tagami Y; Sawazumi T; Takemura T; Komatsu S; Hagiwara E; Ogura T
Respir Investig; 2024 Jul; 62(4):513-516. PubMed ID: 38615375
[TBL] [Abstract][Full Text] [Related]
2. A case of drug-induced organizing pneumonia caused by amikacin liposome inhalation suspension.
Takao D; Takeda K; Takazono T; Ozasa M; Ito Y; Ashizawa N; Hirayama T; Iwanaga N; Takemoto S; Ide S; Tashiro M; Hosogaya N; Kido T; Sakamoto N; Obase Y; Okano S; Izumikawa K; Yanagihara K; Mukae H
J Infect Chemother; 2023 Aug; 29(8):806-808. PubMed ID: 37098378
[TBL] [Abstract][Full Text] [Related]
3. Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by
Griffith DE; Eagle G; Thomson R; Aksamit TR; Hasegawa N; Morimoto K; Addrizzo-Harris DJ; O'Donnell AE; Marras TK; Flume PA; Loebinger MR; Morgan L; Codecasa LR; Hill AT; Ruoss SJ; Yim JJ; Ringshausen FC; Field SK; Philley JV; Wallace RJ; van Ingen J; Coulter C; Nezamis J; Winthrop KL;
Am J Respir Crit Care Med; 2018 Dec; 198(12):1559-1569. PubMed ID: 30216086
[No Abstract] [Full Text] [Related]
4. Long-term amikacin liposome inhalation suspension in cystic fibrosis patients with chronic P. aeruginosa infection.
Bilton D; Fajac I; Pressler T; Clancy JP; Sands D; Minic P; Cipolli M; Galeva I; Solé A; Quittner AL; Jumadilova Z; Ciesielska M; Konstan MW;
J Cyst Fibros; 2021 Nov; 20(6):1010-1017. PubMed ID: 34144923
[TBL] [Abstract][Full Text] [Related]
5. Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease.
Shirley M
Drugs; 2019 Apr; 79(5):555-562. PubMed ID: 30877642
[TBL] [Abstract][Full Text] [Related]
6. Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis.
Bilton D; Pressler T; Fajac I; Clancy JP; Sands D; Minic P; Cipolli M; Galeva I; Solé A; Quittner AL; Liu K; McGinnis JP; Eagle G; Gupta R; Konstan MW;
J Cyst Fibros; 2020 Mar; 19(2):284-291. PubMed ID: 31451351
[TBL] [Abstract][Full Text] [Related]
7. Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure.
Griffith DE; Thomson R; Flume PA; Aksamit TR; Field SK; Addrizzo-Harris DJ; Morimoto K; Hoefsloot W; Mange KC; Yuen DW; Ciesielska M; Wallace RJ; van Ingen J; Brown-Elliott BA; Coulter C; Winthrop KL;
Chest; 2021 Sep; 160(3):831-842. PubMed ID: 33887244
[TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease.
Rubino CM; Onufrak NJ; van Ingen J; Griffith DE; Bhavnani SM; Yuen DW; Mange KC; Winthrop KL
Eur J Drug Metab Pharmacokinet; 2021 Mar; 46(2):277-287. PubMed ID: 33595792
[TBL] [Abstract][Full Text] [Related]
9. Amikacin Liposome Inhalation Suspension for
Winthrop KL; Flume PA; Thomson R; Mange KC; Yuen DW; Ciesielska M; Morimoto K; Ruoss SJ; Codecasa LR; Yim JJ; Marras TK; van Ingen J; Wallace RJ; Brown-Elliott BA; Coulter C; Griffith DE
Ann Am Thorac Soc; 2021 Jul; 18(7):1147-1157. PubMed ID: 33326356
[No Abstract] [Full Text] [Related]
10. Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use.
Hoy SM
Clin Drug Investig; 2021 Apr; 41(4):405-412. PubMed ID: 33723805
[TBL] [Abstract][Full Text] [Related]
11. The Use of Amikacin Liposome Inhalation Suspension (Arikayce) in the Treatment of Refractory Nontuberculous Mycobacterial Lung Disease in Adults.
Khan O; Chaudary N
Drug Des Devel Ther; 2020; 14():2287-2294. PubMed ID: 32606598
[TBL] [Abstract][Full Text] [Related]
12. Features of transbronchial lung cryobiopsy-diagnosed fibrotic hypersensitivity pneumonitis.
Zhan X; Du Y; Luo J; Que Y; Hu C; Xu L; Wang Z; Wu Y; Jin M; Zheng C; Gao Y; Chang C; Li H; Tong Z; Xu G
Clin Respir J; 2023 Jan; 17(1):50-58. PubMed ID: 36397265
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and Management of Drug-Induced Interstitial Lung Disease Associated with Amikacin Liposome Inhalation Suspension in Refractory
Hashimoto K; Nii T; Sumitani H; Yokoyama M; Miyamoto S; Mihashi Y; Nagata Y; Matsuki T; Tsujino K; Miki K; Kida H
Infect Drug Resist; 2023; 16():6629-6634. PubMed ID: 37840829
[TBL] [Abstract][Full Text] [Related]
14. Waterproofing spray-associated pneumonitis review: Comparison with acute eosinophilic pneumonia and hypersensitivity pneumonitis.
Shimoda M; Tanaka Y; Fujiwara K; Furuuchi K; Osawa T; Morimoto K; Yano R; Kokutou H; Yoshimori K; Ohta K
Medicine (Baltimore); 2021 Mar; 100(10):e25054. PubMed ID: 33725891
[TBL] [Abstract][Full Text] [Related]
15. Alveolar proteinosis with hypersensitivity pneumonitis: a new clinical phenotype.
Verma H; Nicholson AG; Kerr KM; Dempsey OJ; Gibbs AR; Campbell I; Black F; Rassl D; Rice AJ; Renzoni EA; Wells AU; Hansell DM
Respirology; 2010 Nov; 15(8):1197-202. PubMed ID: 20920129
[TBL] [Abstract][Full Text] [Related]
16. Robustness of aerosol delivery of amikacin liposome inhalation suspension using the eFlow® Technology.
Li Z; Perkins W; Cipolla D
Eur J Pharm Biopharm; 2021 Sep; 166():10-18. PubMed ID: 34082122
[TBL] [Abstract][Full Text] [Related]
17. Amikacin liposome inhalation suspension for Mycobacterium avium complex pulmonary disease: A subgroup analysis of Japanese patients in the randomized, phase 3, CONVERT study.
Morimoto K; Nonaka M; Yamazaki Y; Nakagawa T; Takasaki J; Tsuyuguchi K; Kitada S; Jumadilova Z; Yuen DW; Ciesielska M; Hasegawa N
Respir Investig; 2024 Mar; 62(2):284-290. PubMed ID: 38277865
[TBL] [Abstract][Full Text] [Related]
18. Amikacin Liposome Inhalation Suspension for
Golia A; Mahmood BR; Fundora Y; Thornby KA; Chahine EB
Sr Care Pharm; 2020 Apr; 35(4):162-170. PubMed ID: 32192565
[No Abstract] [Full Text] [Related]
19. Amikacin liposome inhalation suspension as a treatment for patients with refractory mycobacterium avium complex lung infection.
Zhang Y; Hill AT
Expert Rev Respir Med; 2021 Jun; 15(6):737-744. PubMed ID: 34039231
[No Abstract] [Full Text] [Related]
20. Laryngeal Injury Due to Amikacin Inhalation for Refractory Mycobacterium avium Complex Infection.
Axiotakis LG; Enver N; Keating CL; Pitman MJ
Chest; 2021 Apr; 159(4):e185-e187. PubMed ID: 34022015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
